Healthcare & Medical Devices Global On demand · 24-48h

Global Rapid 16S rDNA Bacterial Identification Kit Market Strategic Research Report

Global Rapid 16S rDNA Bacterial Identification Kit Market St…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Rapid 16S rDNA Bacterial Identification Kit Market
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Basic, Expanded

By Application: Medical Industry, Environmental Monitoring, Food Testing, Other

Key Players: QIAGEN, Chuangling Bio, Thermo Fisher Scientific, Bio-Rad Laboratories, Takara Bio, Zymo Research, Promega Corporation, New England Biolabs, LGC Biosearch Technologies, Guangzhou Qihui Biotechnology, Shanghai Yuduo Biotechnology, Xiamen Yanke Biotechnology, Shanghai Jiemei Gene Pharmaceutical Technology, Shanghai Yiji Industry, Xiamen Huijia Biotechnology, Beijing Biotech Biotechnology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2024 · forecast to 2032
Length: 137 pages

Overzicht

Scope of the Report

The rapid 16S rDNA bacterial identification kit is a kit that integrates modern molecular biology technology. It uses 16S rDNA (ribosomal RNA gene) as a molecular marker for bacterial classification, and achieves rapid and accurate identification of bacterial species through PCR (polymerase chain reaction) amplification, sequencing and sequence alignment. The kit simplifies the tedious steps in the traditional bacterial identification process, such as the extraction and purification of genomic DNA, greatly shortening the time from sampling to obtaining identification results. The 16S rDNA sequence is highly specific and diverse in bacterial taxonomy. By comparing and analyzing its sequence, accurate identification of bacterial species can be achieved. The kit can detect extremely low concentrations of bacterial samples, such as bacteria as low as 10^4/mL, and is suitable for the rapid identification of difficult-to-culture, precious samples or unknown bacteria that cannot be identified by phenotype. It can be used for the identification of various types of bacterial samples, including logarithmic growth period bacterial liquid, bacterial plaque, glycerol bacteria, etc., to meet the needs of different experiments and research.

16S rDNA has become the "molecular clock" of bacterial taxonomy research due to its high diversity of sequences among species, and is known as the "bacterial fossil". Through the sequence analysis of 16S rDNA, strains with abnormal phenotypes, difficult to proliferate or rarely isolated can be identified, and the identification effect of difficult-to-culture or new pathogens is better. Rapid 16S rDNA bacterial identification kits are widely used in medical, scientific research, environmental monitoring and other fields. In the medical field, it can help doctors quickly diagnose infectious diseases and guide clinical medication; in the field of scientific research, it is used for microbial diversity research, pathogenic microorganism identification, etc.; in the field of environmental monitoring, it is used for microbial detection in water quality, soil and other samples. In summary, the market for rapid 16S rDNA bacterial identification kits has broad development prospects and huge market potential.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Rapid 16S rDNA Bacterial Identification Kit market?

What factors are driving Rapid 16S rDNA Bacterial Identification Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Rapid 16S rDNA Bacterial Identification Kit market opportunities vary by end market size?

How does Rapid 16S rDNA Bacterial Identification Kit break out by Type, by Application?

This report presents a comprehensive overview of the global Rapid 16S rDNA Bacterial Identification Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Basic
  • Expanded

Segment by Application

  • Medical Industry
  • Environmental Monitoring
  • Food Testing
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Rapid 16S rDNA Bacterial Identification Kit market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Medical Industry, Environmental Monitoring, Food Testing evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type
BasicExpanded
By Application
Medical IndustryEnvironmental MonitoringFood TestingOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Basic
  • 3.1.3 Expanded
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Medical Industry
  • 4.1.3 Environmental Monitoring
  • 4.1.4 Food Testing
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 QIAGEN
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Chuangling Bio
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Thermo Fisher Scientific
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Bio-Rad Laboratories
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Takara Bio
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Zymo Research
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Promega Corporation
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 New England Biolabs
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 LGC Biosearch Technologies
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Guangzhou Qihui Biotechnology
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Shanghai Yuduo Biotechnology
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Xiamen Yanke Biotechnology
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Shanghai Jiemei Gene Pharmaceutical Technology
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Shanghai Yiji Industry
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Xiamen Huijia Biotechnology
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Beijing Biotech Biotechnology
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is Rapid 16S rDNA Bacterial Identification Kit?
The rapid 16S rDNA bacterial identification kit is a kit that integrates modern molecular biology technology. It uses 16S rDNA (ribosomal RNA gene) as a molecular marker for bacterial classification, and achieves rapid and accurate identification of bacterial species through PCR (polymerase chain reaction) amplification, sequencing and sequence alignment.
How is the Rapid 16S rDNA Bacterial Identification Kit market segmented by type?
By type, the market is segmented into Basic and Expanded.
What are the key applications of Rapid 16S rDNA Bacterial Identification Kit?
Key applications covered include Medical Industry, Environmental Monitoring, Food Testing and Other.
Which companies are profiled in the Rapid 16S rDNA Bacterial Identification Kit market report?
Key players profiled include QIAGEN, Chuangling Bio, Thermo Fisher Scientific, Bio-Rad Laboratories, Takara Bio, Zymo Research, Promega Corporation and New England Biolabs, among 16 companies covered in total.
What geographies does the Rapid 16S rDNA Bacterial Identification Kit market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Rapid 16S rDNA Bacterial Identification Kit?
What factors are driving Rapid 16S rDNA Bacterial Identification Kit market growth, globally and by region?
Who should buy the Rapid 16S rDNA Bacterial Identification Kit market report?
The report is intended for manufacturers and solution providers, distributors and end users in Medical Industry, Environmental Monitoring and Food Testing, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Rapid 16S rDNA Bacterial Identification Kit market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.